Back to stock search

Ascendis Pharma AS

ASND•NASDAQ•HEALTHCARE
$267.79+1.07 (+0.40%)
Market closed•Prev close $266.72
Save to watchlist

AlphaYou read

Buy

Live call

C-suite insider bought $22K of ASND this 14d.

Saved Jun 4, 2026· tracking vs the S&P 500

1 sourceOld
AlphaYou target

+5% to +15%

Over 30 days · baseline band

Analyst target

+8.7% ($291.12)

Over 12 months

Looks good

EVP & Chief Financial Officer SMITH SCOTT THOMAS bought $22K

Watch risk

Review the source panels before acting.

Tracking

Day 28 of 30D, +7.6% vs the S&P so far.

What's driving it

  • Smart money
  • Fundamentals
  • Technicals
  • Macro
Set alertOpen latest callView proofCheck the math

Price

Stock chart

3calls marked
Prior call3

Snapshot

Quick facts

Updated Jul 2
Market cap
$17.49B
52-week range
$160.86 - $271.89
Volume
541.8K
Sector
HEALTHCARE

Analysts

What do analysts expect?

Live

Current

$267.79

Target

$291.12

+23.33 (+8.7%) possible upside12 months

Saved calls

Recent AlphaYou calls for this stock

LiveAll calls
  • LONGJun 4
    Insider Buy

    C-suite insider bought $22K of ASND this 14d.

    Public call·Results pending
  • LONGJun 2
    Insider Cluster

    C-suite + 1 other insiders bought $167K of ASND this 14d.

    Public call·Results pending
  • LONGMay 29
    Insider Buy

    Insider bought $95K of ASND this 14d.

    Public call·Results pending

Smart money

What big buyers and insiders are doing

Live5 items

  • insider buy

    EVP & Chief Financial Officer SMITH SCOTT THOMAS bought $22K

    +65700.0

  • insider buy

    EVP & Chief Financial Officer SMITH SCOTT THOMAS bought $56K

    +167490.0

  • insider buy

    Director BIENAIME JEAN JACQUES bought $112K

+223124.0

  • insider buy

    Director BIENAIME JEAN JACQUES bought $95K

    +190241.0

  • short interest change

    Short interest fell -22.5% as of 2026-04-30 (twice-monthly FINRA)

    +2.0